benzbromarone
Uricosuric that acts by increasing uric acid clearance. It is used in the treatment of gout.
Ligand Summary
UNII: 4POG0RL69O
PubChem: 2333
ChEMBL: CHEMBL388590
DrugCentral: 318
LyCHI: L1B5DR6HXMQL
Target Activities
SLC22A12
Solute carrier family 22 member 12
8 Activities
Items per page:
1 – 8 of 8
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
|---|---|---|---|---|---|---|
IC50 | 7.66 | MedChemComm, (2016) 7:8:1587 | ||||
IC50 | 7.58 | J. Med. Chem., (2011) 54:8:2701 | ||||
IC50 | 7.46 | J. Med. Chem., (2011) 54:8:2701 | ||||
IC50 | 6.92 | Bioorg Med Chem Lett, (2017) 27:9:1919 | ||||
IC50 | 6.66 | Eur J Med Chem, (2019) 166:None:186 | ||||
IC50 | 6.52 | Drug Metab. Dispos., (2007) 35:6:981 | ||||
IC50 | 6.12 | None, (2014) None:None:None | ||||
IC50 | 7.59 | INHIBITOR | ||||
CYP2C9
Cytochrome P450 2C9
5 Activities
Items per page:
1 – 5 of 5
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
|---|---|---|---|---|---|---|
AC50 | 8.1 | None, None:None:None | ||||
IC50 | 7.8 | None, None:None:None | ||||
Ki | 7.72 | J. Med. Chem., (2004) 47:27:6768 | ||||
Ki | 7.72 | J. Med. Chem., (2008) 51:3:648 | ||||
Ki | 7.72 | Bioorg. Med. Chem., (2008) 16:7:4064 | ||||
ABCC1
Multidrug resistance-associated protein 1
2 Activities
Items per page:
1 – 2 of 2
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
|---|---|---|---|---|---|---|
Ki | 6.72 | Bioorg. Med. Chem., (2011) 19:10:3249 | ||||
Ki | 6.72 | |||||
AKR1C1
Aldo-keto reductase family 1 member C1
2 Activities
Items per page:
1 – 2 of 2
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
|---|---|---|---|---|---|---|
IC50 | 7.32 | J. Med. Chem., (2009) 52:10:3259 | ||||
IC50 | 7.32 | |||||